Actively Recruiting
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
Led by Liao Ning · Updated on 2015-03-17
222
Participants Needed
1
Research Sites
608 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Whether the patients with low grade ductal carcinoma in situ breast cancer should accept radiationtherapy is uncertain.Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation during surgery followed by external-beam radiation to the entire breast may kill more tumor cells.The clinical trial is conducting to find out the effectiveness of radiation therapy during surgery in treating women who have undergone breast-conversing surgery for low grade ductal carcinoma in situ breast cancer.
CONDITIONS
Official Title
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Tumor diameter less than 5 cm
- Low grade ductal carcinoma in situ
- Candidate for breast-conserving surgery
- Have undergone lumpectomy with negative or minimal margin involvement
- Currently undergoing re-excision of the biopsy cavity and/or sentinel lymph node biopsy or axillary lymph node dissection
- No evidence of metastatic disease
- Provided informed consent
You will not qualify if you...
- No informed consent
- Tumor size greater than 5 cm
- Intermediate or high grade ductal carcinoma in situ
- Presence of invasive carcinoma
- No indication for a radiation boost
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangdong Academy of Medical Sciences
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
L
Liao Ning, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here